Loading...

Aflac Incorporated

0H68.LLSE
Financial Services
Insurance - Life
£102.61
£1.25(1.24%)

Aflac Incorporated (0H68.L) Stock Overview

Explore Aflac Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
1.52%
1.52%
Profit Growth
£6.60
16.83%
EPS Growth
£6.60
24.97%
Operating Margin
25.70%
21.95%
ROE
13.91%
16.83%
Dividend Yield
0.00%
20.25%
Analyst Recommendations data is not available for 0H68.LAnalyst Recommendations details for 0H68.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.

CEO

Mr. Daniel Paul Amos

Employees

12,694

Headquarters

1932 Wynnton Road, Columbus, GA

Founded

2018

Frequently Asked Questions